Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017 by Robin Tricoles, University of Arizona
Credit: CC0 Public Domain

Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids often are prescribed to allay the agony.

But opioids recently have been denounced for their addictive nature. This summer, the nation's opioid crisis was declared a national emergency.

Long before that, Todd Vanderah of the University of Arizona had been seeking ways to create alternative analgesics. He and his colleagues are now seeing promise in a specific class of chemical compounds that may help people find pain relief brought about by metastatic .

Those compounds, says Vanderah, head of the Department of Pharmacology in the College of Medicine – Tucson, are unique, non-psychotropic cannabinoids. In other words, they do not bring about the euphoria typically associated with cannabinoids. What's more, these particular chemical compounds help slow bone loss, unlike opioids, while slowing the proliferation of the cancer.

Vanderah and his colleagues have published several peer-reviewed studies investigating unique cannabinoids' analgesic viability as well as the mechanisms behind opioids' addictive properties.

The latest studies show that sustained opioid use in metastatic cancer may enhance bone loss, says Vanderah, an expert on opioid addiction, whereas non-psychotropic cannabinoids actually inhibit and pain.

A recent publication by Vanderah and his colleagues in the journal Neuropharmacology demonstrated that the combination of the non-psychotropic cannabinoid with a low dose of an opioid resulted in while significantly reducing the addictive property of the .

Researchers are now using different kinds of cannabinoids to slow the proliferation and spread of cancer. Vanderah says there are 400 within a marijuana plant, with only one or two being tested for medicinal use. Studies so far have shown that cannabinoids slow the spread of brain and colon cancer in addition to breast cancer.

"It won't kill the cancer cells off, but it slows the proliferation," he says, adding that this finding was something of a delightful surprise. "Now we're trying to figure out how the cannabinoid slows the breast proliferation.

"That's one of those things I love about science: when we don't expect something to happen and then we end up working another several years on a project that we thought would be done with one or two publications."

Explore further: Omega-3 fatty acids fight inflammation via cannabinoids

More information: Shaness A. Grenald et al. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists, Neuropharmacology (2016). DOI: 10.1016/j.neuropharm.2016.12.008

Related Stories

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

Breast cancer patients on opioids less likely to stick to vital treatment

September 1, 2017
A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.

Medical marijuana's underexplored potential for helping opioid addiction

February 2, 2017
A small human pilot study, along with a number of animal studies, are revealing that cannabinoids, extracts of cannabis legally sold as medical marijuana, could reduce cravings and ease withdrawal symptoms in heroin users. ...

Day-supply of opioid Rx factor in likelihood of long-term use

August 24, 2017
(HealthDay)—The days supplied is far more important than the dosage level or even the type of pain being treated in risk of opioid use disorder following opioid prescription, according to a study published recently in The ...

Cannabinoids used in sequence with chemotherapy are a more effective treatment for cancer

June 5, 2017
New research has confirmed that cannabinoids - the active chemicals in cannabis - are effective in killing leukaemia cells, particularly when used in combination with chemotherapy treatments.

Medical marijuana helpful for cancer-linked symptoms

December 18, 2014
(HealthDay)—Cannabis and cannabinoid pharmaceuticals can be helpful for nausea and vomiting, pain, and weight loss associated with cancer, according to research published online Dec. 10 in CA: A Cancer Journal for Clinicians.

Recommended for you

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym
1 / 5 (1) Sep 04, 2017
The "opiod epidemic"? You guys need to look up the definition of "epidemic." You also need to do some research on opiod "addiction."

Let's bust two myths: America does not have an epidemic, and opiods are not universally addicting. Contrary to myth. If they were as addicting "as seen on TV," every major surgery would produce a junkie. During the Vietnam war, officials feared that tens of thousands of GIs, heroin users in the war zone, would bring their drug habits home when they were discharged from service --- it didn't happen. Why?

The war on drugs, a major federal make-work scheme, is simply in need of a new bogeyman to replace the old one, marijuana: That is why the "epidemic," which you might think in a rational world would evoke a policy response appropriate to a public health or social problem, instead is dumped on DEA. There is no desire ever to end this "war" --- in fact, it is unwinnable since it is rooted in the basic human need to avoid pain.
Munix
not rated yet Sep 04, 2017
Met a DEA agent once who told me that he had cars and mortgage to pay.

And in heart of hearts he could care less if some idiot wanted to stick some drug in his veins.

So for him, it was job. Whether right or wrong, it was simply a job.
Shootist
not rated yet Sep 04, 2017
Non-psychotropic cannabinoids show promise for pain relief


Real cannabis actually does relieve pain.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.